14 completed, 7 recruiting, 3 not yet recruiting, 1 active not recruiting. 28 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 28 | Completed 14, Recruiting 7, Not yet recruiting 3, Active not recruiting 1, Enrolling by invitation 1, Terminated 1, Unknown 1 |
Follow Hyperlipidemias: new trials by email Literature Review of Hyperlipidemias trials Research Report on Hyperlipidemias
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Team-Based Shared Decision-Making Program in Cardiovascular-Kidney-Metabolic Health (Healthy Heart - CKM) Team-based shared decision-making - Hypertension (HTN), Diabetes (DM) | Early Phase 1 | Not yet recruiting | Johns Hopkins University | 94 | 2026-10-30 | 2026-10-19 |
| CS-121 APOC3 Base Editing in Severe Hypertriglyceridemia CS-121 - Severe Hypertriglyceridemia (sHTG) | Early Phase 1 | Not yet recruiting | CorrectSequence Therapeutics Co., Ltd | 15 | 2026-06-15 | 2026-06-18 |
| CS-121 APOC3 Base Editing in Children and Adolescents With Hyperchylomicronemia CS-121 - Hyperchylomicronemia | Early Phase 1 | Recruiting | Shanghai Jiao Tong University School of Medicine | 15 | 2026-01-26 | 2026-01-28 |
| CS-121 APOC3 Base Editing in FCS CS-121 - Familial Chylomicronemia Syndrome (FCS) | Early Phase 1 | Recruiting | CorrectSequence Therapeutics Co., Ltd | 15 | 2025-10-15 | 2026-02-11 |
| Truway Diagnostic Tools in Primary Care Truway Portable Ultrasound Device, Truway Blood Glucose Monitor, Standard Oral Hypoglycemic Agent - Chronic Disease, Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight | Early Phase 1 | Enrolling by invitation | Truway Health, Inc. | 200 | 2025-10-01 | 2026-11-05 |
| The Effect of Providing Genetic Risk Information on Lifestyle Behaviors in African Americans Color Genomics Genetic Testing Panels - Diabetes, Hypercholesterolaemia | Early Phase 1 | Completed | Pennington Biomedical Research Center | 60 | 2025-09-22 | 2026-09-24 |
| Differential Thrombogenesis by EPA and DHA Mediated by HDL EPA, DHA - Lipid Metabolism Disorders, Hypertriglyceridemia | Early Phase 1 | Recruiting | The Miriam Hospital | 80 | 2025-07-10 | 2025-10-01 |
| Akkermansia Muciniphilia and Metabolic Side Effects of ADT Apple Cider Vinegar - Prostate Cancer, Metabolic Syndrome | Early Phase 1 | Recruiting | Western University | 30 | 2025-07-02 | 2025-08-20 |
| Safety and Efficacy Study of NGGT006 in Refractory Hypercholesterolemia Patients NGGT006 - Refractory Hypercholesterolemia, Familial Hypercholesterolemia | Early Phase 1 | Not yet recruiting | Suzhou Municipal Hospital | 9 | 2024-06-01 | 2024-04-17 |
| Clinical Exploration Trial of YOLT-101 in the Treatment of Familial Hypercholesterolemia (FH) YOLT-101 - Familial Hypercholesterolemia | Early Phase 1 | Recruiting | RenJi Hospital | 20 | 2024-05-24 | 2025-04-30 |
| Clinical Exploration Trial of YOLT-101 in the Treatment of Familial Hypercholesterolemia (FH) YOLT-101 - Familial Hypercholesterolemia | Early Phase 1 | Unknown | The First Affiliated Hospital of Bengbu Medical University | 13 | 2024-04-01 | 2024-06-17 |
| Time Restricted Eating in Sleep Apnea Time restricted eating - Time Restricted Eating, Obstructive Sleep Apnea | Early Phase 1 | Recruiting | University of California, San Diego | 80 | 2024-01-05 | 2024-01-16 |
| NGGT006 Gene Therapy for Homozygous Familial Hypercholesterolemia NGGT006 - Homozygous Familial Hypercholesterolemia | Early Phase 1 | Recruiting | First Affiliated Hospital Xi'an Jiaotong University | 21 | 2023-10-29 | 2026-09-03 |
| Pilot Study of GLY-LOW Supplementation in Postmenopausal Women With Obesity GLY-LOW - Insulin Resistance, Obesity | Early Phase 1 | Completed | Hoskinson Health and Wellness Clinic | 13 | 2023-07-27 | 2025-06-10 |
| Weight Loss, Blood Sugar and Blood Lipid Effects of Tetrahydrocannabivarin (THCV) Impregnated Mucoadhesive Strips Tetrahydrocannabivarin, Placebo - Metabolic Syndrome, Morbid Obesity | Early Phase 1 | Completed | Medical Life Care Planners, LLC | 56 | 2022-01-04 | 2022-10-10 |
| Cholesterol Disruption in Combination With the Standard of Care in Patients With Advanced Pancreatic Adenocarcinoma Cholesterol metabolism disruption - Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer | Early Phase 1 | Active not recruiting | CHU de Quebec-Universite Laval | 3 | 2021-10-04 | 2026-03-19 |
| Pediatric Reporting of Adult-Onset Genomic Results Child(ren) receive an adult-onset result, Child(ren) received a pediatric-onset result, Control - Negative Result - Hereditary Breast and Ovarian Cancer Syndrome, Lynch Syndrome | Early Phase 1 | Completed | Geisinger Clinic | 162 | 2020-11-25 | 2026-04-09 |
| Protective Effect of Zingiber Officinale L. Extract in Hypertensive Patients Zingiber officinale L. tablets, Simvastatin 20mg - The Main Focus of This Study is to Evaluate the Safety of Zingiber Officinale L. Tablets as Hypolipidemic Agent in Hypertensive Patients | Early Phase 1 | Completed | Jinnah Sindh Medical University | 40 | 2018-01-01 | 2023-01-12 |
| The Effects of Rhus Coriaria L. on Serum Lipid Levels of Patients With Hyperlipidemia Rhus Coriaria L. (Rhus), Placebo - Hyperlipidemias | Early Phase 1 | Completed | Shiraz University of Medical Sciences | 74 | 2014-12-01 | 2016-06-07 |
| Retinoic Acid Supplementation and Subjects With Hypercholesterolemia retinoic acid, placebo - Hypercholesterolemia | Early Phase 1 | Completed | Sun Yat-sen University | 130 | 2014-11-01 | 2015-07-15 |
Showing 20 of 28. Sign in to see all of them.
Hypercholesterolemia (8) · Obesity (7) · Metabolic Syndrome (6) · Overweight (6) · Hyperlipoproteinemia Type II (5) · Diabetes Mellitus (4) · Hypertension (4) · Hypertriglyceridemia (4) · Cardiovascular Diseases (3) · Hyperglycemia (3) · Pancreatitis (2) · Bone Diseases (1) · Chronic Disease (1) · Cognitive Dysfunction (1)
Dyslipidemias (28) · Metabolic Diseases (28) · Nutritional and Metabolic Diseases (28) · Lipid Metabolism Disorders (27) · Pathological Conditions, Signs and Symptoms (12) · Body Weight (11) · Signs and Symptoms (11) · Nutrition Disorders (10) · Overnutrition (10) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (9) · Genetic Diseases, Inborn (9) · Glucose Metabolism Disorders (9) · Metabolism, Inborn Errors (9) · Hyperlipoproteinemias (8)
Ezetimibe (2) · Atorvastatin (1) · Chenodeoxycholic Acid (1) · Colchicine (1) · Docosahexaenoic Acids (1) · Eicosapentaenoic Acid (1) · Linseed Oil (1) · Phytosterols (1) · Simvastatin (1) · Tretinoin (1) · evolocumab (1) · ginger extract (1)
CorrectSequence Therapeutics Co., Ltd (2) · University of Jena (2) · Arizona State University (1) · CHU de Quebec-Universite Laval (1) · First Affiliated Hospital Xi'an Jiaotong University (1) · Geisinger Clinic (1) · Hoskinson Health and Wellness Clinic (1) · Jinnah Sindh Medical University (1) · Johns Hopkins University (1) · Medical Life Care Planners, LLC (1) · Pennington Biomedical Research Center (1) · RenJi Hospital (1) · Scripps Translational Science Institute (1) · Shanghai Jiao Tong University School of Medicine (1) · Shanghai University of Traditional Chinese Medicine (1)
United States (9) · China (7) · Canada (2) · Germany (2) · Iran (1) · Mexico (1) · Pakistan (1) · Switzerland (1)
Katrin Kuhnt, Dr. rer. nat (2) · Adam H Buchanan, MS, MPH, CGC (1) · Anne Gangloff, MD PhD FRCPC (1) · Anne-Marie Carreau, MD FRCPC (1) · Arturo Jimenez-Cruz, MD (1) · Cheryl Himmelfarb, PhD (1) · Francine Aubin, MD FRCPC (1) · Guang Ji, MD (1) · Jennifer L. Caldwell, PhD, MPH, MS (1) · Kory Floyd, PhD (1) · Majid Nimruzi, M.D. (1) · Melissa Huynh, MD (1)
PMID 26892399, PMID 21768544, PMID 24229084, PMID 24553695, PMID 29397092, PMID 32414353, PMID 41193187, PMID 41776075, PMID 42243546
1UL1TR001114-01 (1), P50MD017338 (1), R01HG009671 (1), R01HL050420 (1), R01HL159204 (1)